Výsledky vyhledávání - "A. Notarantonio"

Report

Systems of Discrete Differential Equations, Constructive Algebraicity of the Solutions

Autor: Notarantonio, Hadrien, Yurkevich, Sergey

In this article, we study systems of $n \geq 1$, not necessarily linear, discrete differential equations (DDEs) of order $k \geq 1$ with one catalytic variable. We provide a constructive and elementary proof of algebraicity of the solutions of such e

Externí odkaz: http://arxiv.org/abs/2310.12812

Zobrazit plný text záznamu

Report

Fast Algorithms for Discrete Differential Equations

Autor: Bostan, Alin, Notarantonio, Hadrien, Din, Mohab Safey El

Discrete Differential Equations (DDEs) are functional equations that relate polynomially a power series $F(t,u)$ in $t$ with polynomial coefficients in a "catalytic" variable $u$ and the specializations, say at $u=1$, of $F(t,u)$ and of some of its p

Externí odkaz: http://arxiv.org/abs/2302.06203

Zobrazit plný text záznamu

Report

Effective algebraicity for solutions of systems of functional equations with one catalytic variable

Autor: Notarantonio, Hadrien, Yurkevich, Sergey

We study systems of $n \geq 1$ discrete differential equations of order $k\geq1$ in one catalytic variable and provide a constructive and elementary proof of algebraicity of their solutions. This yields effective bounds and a systematic method for co

Externí odkaz: http://arxiv.org/abs/2211.07298

Zobrazit plný text záznamu

Akademický článek

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation

Autor: Anne-Béatrice Notarantonio, Allan Bertrand, Romain Piucco, Ghislain Fievet, Hervé Sartelet, Laura Boulangé, Natalia de Isla, Marcelo De Carvalho Bittencourt, Sébastien Hergalant, Marie-Thérèse Rubio, Maud D’Aveni

Publikováno v: Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-6 (2024)

Abstract Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment for myeloid malignancies such as some acute myeloid leukemias (AML) and high-risk myelodysplastic syndromes (MDS). It aims to eradicate

Externí odkaz: https://doaj.org/article/93db9b55384743518fd9aa8c038be339